Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART.

Vera JH, Bracchi M, Alagaratnam J, Lwanga J, Fox J, Winston A, Boffito M, Nelson M.

Brain Sci. 2019 Aug 9;9(8). pii: E195. doi: 10.3390/brainsci9080195.


Recent advances in HIV-associated Kaposi sarcoma.

Dalla Pria A, Pinato DJ, Bracchi M, Bower M.

F1000Res. 2019 Jun 26;8. pii: F1000 Faculty Rev-970. doi: 10.12688/f1000research.17401.1. eCollection 2019. Review.


Level of agreement between frequently used cardiovascular risk calculators in people living with HIV.

Dhillon S, Sabin CA, Alagaratnam J, Bagkeris E, Post FA, Boffito M, Anderson J, Vera J, Williams I, Johnson M, Sachikonye M, Babalis D, Mallon PW, Winston A; Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study.

HIV Med. 2019 May;20(5):347-352. doi: 10.1111/hiv.12731. Epub 2019 Mar 14.


Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.

De Francesco D, Underwood J, Bagkeris E, Boffito M, Post FA, Mallon P, Vera JH, Williams I, Anderson J, Johnson M, Sabin CA, Winston A; Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study.

HIV Med. 2019 Apr;20(4):274-285. doi: 10.1111/hiv.12714. Epub 2019 Feb 8.


High-risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV-positive men who have sex with men.

Pool E, Winston A, Bagkeris E, Vera JH, Mallon P, Sachikonye M, Post FA, Pozniak A, Boffito M, Anderson J, Williams I, Johnson M, Burgess L, Sabin CA; Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study team.

HIV Med. 2019 Feb;20(2):131-136. doi: 10.1111/hiv.12690. Epub 2018 Dec 12.


Patterns of Co-occurring Comorbidities in People Living With HIV.

De Francesco D, Verboeket SO, Underwood J, Bagkeris E, Wit FW, Mallon PWG, Winston A, Reiss P, Sabin CA; Pharmacokinetic and Clinical Observations in PeoPle Over fiftY (POPPY) study and the AGEhIV Cohort Study.

Open Forum Infect Dis. 2018 Oct 24;5(11):ofy272. doi: 10.1093/ofid/ofy272. eCollection 2018 Nov.


Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.

Gatell JM, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Martinez E, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Stephan C, Rockstroh J, Giacomelli A, Vera J, Bernardino JI, Winston A, Saumoy M, Gras J, Katlama C, Pozniak AL; European Network for AIDS Treatment 022 (NEAT022) Study Group .

Clin Infect Dis. 2019 Feb 1;68(4):597-606. doi: 10.1093/cid/ciy505.


High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders.

Calcagno A, Lucchini A, Caracciolo D, Balbiano R, Bracchi M, Sordella F, Gregori G, Lipani F, Audagnotto S, Chiriotto M, Cavaglia G, Ghisetti V, Di Perri G, Bonora S.

Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.


Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safety.

Bracchi M, Stuart D, Castles R, Khoo S, Back D, Boffito M.

AIDS. 2015 Aug 24;29(13):1585-92. doi: 10.1097/QAD.0000000000000786.


Observing the revolution: A commentary on the new GeSIDA HIV guidelines.

Bracchi M, Pozniak A.

Enferm Infecc Microbiol Clin. 2015 Oct;33(8):505-7. doi: 10.1016/j.eimc.2015.08.003. Epub 2015 Sep 8. No abstract available.


Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.

Calcagno A, Simiele M, Alberione MC, Bracchi M, Marinaro L, Ecclesia S, Di Perri G, D'Avolio A, Bonora S.

Clin Infect Dis. 2015 Jan 15;60(2):311-7. doi: 10.1093/cid/ciu773. Epub 2014 Oct 3.


High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis.

Calcagno A, Cusato J, Simiele M, Motta I, Audagnotto S, Bracchi M, D'Avolio A, Di Perri G, Bonora S.

J Antimicrob Chemother. 2014 Jan;69(1):241-5. doi: 10.1093/jac/dkt339. Epub 2013 Aug 23.

Supplemental Content

Loading ...
Support Center